These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4210128)

  • 1. Comparative in vitro activity of kanendomycin, kanamycin, gentamicin and streptomycin against 100 consecutive cultures of tubercle bacilli recovered from patients.
    Tanzil HO; Utomo RR
    Paediatr Indones; 1974; 11(1):27-31. PubMed ID: 4210128
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculostatic effect of gentamicin in vitro.
    Jedlicková Z; Sulová J; SpurnM
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(4):516-7. PubMed ID: 4980365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis].
    De Stasio A; Puccini G
    Antibiotica; 1968 Dec; 6(4):358-62. PubMed ID: 4984521
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 10. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 12. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiology of aminoglycoside resistance in Streptococcus except in group D Streptococcus and Enterococcus].
    Le Pennec MP; Lusina D; Mathieu P; Giacomini T
    Pathol Biol (Paris); 1991 May; 39(5):489-90. PubMed ID: 1881680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK; Kanes W; Davidson PT; Moulding TS
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial action of Kanamycin and Kanendomycin and genetic aspects of tolerance].
    Mitsuhashi S; Hashimoto H; Fujii T
    Nihon Ishikai Zasshi; 1969 Sep; 62(6):519-24. PubMed ID: 4982398
    [No Abstract]   [Full Text] [Related]  

  • 18. [A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. A fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria].
    Takenaka T; Tsukamura M
    Kekkaku; 1970 Mar; 45(3):93-6. PubMed ID: 4987506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of infection by drug resistant tubercle bacilli. 4. Experimental studies on infection by low-grade-resistant tubercle bacilli].
    Osato T; Kudo K; Aoki M
    Kekkaku; 1968 Dec; 43(12):503-8. PubMed ID: 4975467
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
    Sugawara I; Zhang J; Li C
    Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.